Newron Pharmaceuticals S.p.A.
Cena
Finančné výkazy zatiaľ nemáme
Firma vykazuje v mene EUR, cena titulu je v mene CHF. Výkazy zatiaľ neprevádzame medzi menami, pretože by z nich násobky (P/E, P/S a ďalšie) vychádzali nesprávne, a preto ich tu neukazujeme. Cenu a jej vývoj vidíte vyššie.
Fundamenty
Načítavam kľúčové čísla…
Insideri, analytici a ľudia
Všetky obchody a zmenyNačítavam insiderov, analytikov a názory…
Co se právě děje
AI souhrnO spoločnosti
Newron Pharmaceuticals S.p.A., a biopharmaceutical company, discovers and develops novel therapies for patients with diseases of the central and peripheral nervous system in Italy and the United States. It offers Xadago (safinamide), a chemical entity for the treatment of Parkinson's in the European Union, the United Kingdom, the United States, Latin America, Switzerland, and Japan. The company's lead compound includes Evenamide, an add-on therapy for the treatment of Schizophrenia and treatment-resistant schizophrenia, which is in Phase III clinical trial; and Ralfinamide for the treatment of rare neuropathic pain indication. It has a strategic partnership with Zambon and Meiji Seika Pharma Co., Ltd. for the commercialization of safinamide. Newron Pharmaceuticals S.p.A. was founded in 1999 and is headquartered in Bresso, Italy.
Český popis pripravujeme.
- Web
- newron.com
- Zamestnanci
- 27
- Krajina
- Itálie
- Dáta od
- 11. 12. 2006